Hello! This special newsletter brings you some key articles from our COVID-19 coverage to date, including a call to completely reboot drug R&D from Claudia Wild, CEO of the Austrian Institute for Health Technology Assessment. 


If you’d like to get all the latest COVID-19 research delivered straight to your inbox every week, The COVID-19 Curator has you covered – and you can subscribe for free.

Charlotte Barker, Editor.

Time to Transform (Re)search and Development
10/08/2020 | Claudia Wild
The drug development system is broken; the COVID-19 pandemic is an opportunity to take a bold step towards accessible and affordable therapies
Small, But Mighty
10/09/2020 | Brent R Stockwell
Small-molecule inhibition of the SARS-CoV-2 viral protease may represent a promising route for therapy
Pandemic Proteomics
An MS-based proteomics platform is painting a picture of variable patient responses to COVID-19
The COVID-19 Pandemic: A Summary
Expert pathologist Fred Plapp offers a summary of the virus causing COVID-19, its effects, and the pandemic’s evolving status
Product Profiles
Increase proteome coverage and confidence in global proteome profiling

Read 3 great scientific stories using FAIMS to improve top-down, TMT, and targeted PRM experiments. Get increased productivity, enhanced selectivity and accurate ID and quantitation. Get the eBook>

Achieve maximum usability and selectivity for proteomics workflows.

The Thermo Scientific™ FAIMS Pro™ interface is a next-generation, differential ion mobility device that enhances performance and usability of our mass spectrometers to enable identification and quantitation of more proteins. Learn more>